Serum Institute of India is expanding its production capacity as it expects sales of life-saving vaccines, including those for malaria and cervical cancer, to double in the next five years.
The world’s largest vaccine maker currently has the capacity to produce 3 billion doses of all types of vaccines each year, but only sells about 1.5 billion doses annually. The Pune-based firm is forecasting that will change.
"As countries increase their health-care budgets, you’re going to see a huge uptake of vaccines that can prevent a lot of diseases," Serum’s Chief Executive Officer Adar Poonawalla said in an interview with Bloomberg TV. "Vaccines have been proven to be the most efficient tool for prevention."
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.